Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation

Free Radical Biology and Medicine

Volumn 41, Issue 6, 2006, Pages 960-972

  Im, Joo Young ^a,b   Kim, Doyeun ^a   Paik, Sang Gi ^b   Han, Pyung Lim ^a  

^a Ewha Womans University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

COX 2; MnTBAP; Neuronal death; NS398; SOD; Superoxide

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ALLOPURINOL; ASCORBIC ACID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENZYME INHIBITOR; GLUTATHIONE; HYDROGEN PEROXIDE; IRON COMPLEX; LIPOPOLYSACCHARIDE; MANGANESE TETRAKIS(4 BENZOIC ACID)PORPHYRIN; MONOAMINE OXIDASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PARGYLINE; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; SUPEROXIDE; TROLOX C; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; ENZYMOLOGY; KNOCKOUT MOUSE; LIPID PEROXIDATION; MOUSE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ASTROCYTES; CELL DEATH; CELL SURVIVAL; CEREBRAL CORTEX; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; FERRIC COMPOUNDS; HYDROGEN PEROXIDE; KINETICS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEURONS; NITROPRUSSIDE; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 33747348720     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.06.001     Document Type: Article

References (61)

1. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
2. Sies H. Strategies of antioxidant defense. Eur. J. Biochem. 215 (1993) 213-219
3. Lewen A., Matz P., and Chan P.H. Free radical pathways in CNS injury. J. Neurotrauma 17 (2000) 871-890
4. Marnett L.J., Rowlinson S.W., Goodwin D.C., Kalgutkar A.S., and Lanzo C.A. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J. Biol. Chem. 274 (1999) 22903-22906
5. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21 (2001) 2-14
6. Niwa K., Haensel S., Ross M.E., and Iadecola C. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ. Res. 88 (2001) 600-608
7. Araki E., Forster C., Dubinsky J.M., Ross M.E., and Iadecola C. Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 32 (2001) 2370-2375
8. Iadecola C., and Alexander M. Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14 (2001) 89-94
9. McGeer P.L., and McGeer E.F. Inflammation and the degenerative diseases of aging. Ann. N.Y. Acad. Sci. 1035 (2004) 104-116
10. Candelario-Jalil E., Ajamieh H.H., Sam S., Martinez G., and Leon Fernandez O.S. Nimesulide limits kainate-induced oxidative damage in the rat hippocampus. Eur. J. Pharmacol. 390 (2000) 295-298
11. Gunasekar P.G., Borowitz J.L., and Isom G.E. Cyanide-induced generation of oxidative species: involvement of nitric oxide synthase and cyclooxygenase-2. J. Pharmacol. Exp. Ther. 285 (1998) 236-241
12. Li L., Prabhakaran K., Shou Y., Borowitz J.L., and Isom G.E. Oxidative stress and cyclooxygenase-2 induction mediate cyanide-induced apoptosis of cortical cells. Toxicol. Appl. Pharmacol. 185 (2002) 55-63
13. Candelario-Jalil E., Alvarez D., Merino N., and Leon O.S. Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neurosci. Res. 47 (2003) 245-253
14. Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M.A., Greco A., Levi G., and Minghetti L. In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J. Neurochem. 81 (2002) 1028-1034
15. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Fernandez A.P., Rodrigo J., Bosca L., and Leza J.C. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28 (2003) 1579-1588
16. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., and Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16 (1996) 2479-2487
17. Caggiano A.O., and Kraig R.P. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72 (1999) 565-575
18. Bal-Price A., and Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21 (2001) 6480-6491
19. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., and Baik E.J. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2. Brain Res. 941 (2002) 1-10
20. Li J., Baud O., Vartanian T., Volpe J.J., and Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. USA 102 (2005) 9936-9941
21. Cho I.K., Im J.Y., Kim D., Kim K.S., Lee J.K., and Han P.L. Protective effects of extracellular glutathione against Zn2+-induced cell death in vitro and in vivo. J. Neurosci. Res. 74 (2003) 736-743
22. Dinchuk J.E., Car B.D., Focht R.J., Johnston J.J., Jaffee B.D., Covington M.B., Contel N.R., Eng V.M., Collins R.J., and Czerniak P.M. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378 (1995) 406-409
23. Im J.Y., Kim D., Lee K.W., Kim J.B., Lee J.K., Kim D.S., Lee Y.I., Ha K.S., Joe C.O., and Han P.L. COX-2 Regulates the insulin-like growth factor I-induced potentiation of Zn(2+)-toxicity in primary cortical culture. Mol. Pharmacol. 66 (2004) 368-376
24. Bindokas V.P., Jordan J., Lee C.C., and Miller R.J. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16 (1996) 1324-1336
25. Zhao H., Kalivendi S., Zhang H., Joseph J., Nithipatikom K., Vasquez-Vivar J., and Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic. Biol. Med. 34 (2003) 1359-1368
26. Daiber A., Oelze M., Coldewey M., Kaiser K., Huth C., Schildknecht S., Bachschmid M., Nazirisadeh Y., Ullrich V., Mulsch A., Munzel T., and Tsilimingas N. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem. Biophys. Res. Commun. 338 (2005) 1865-1874
27. Kim D., Joe C.O., and Han P.L. Extracellular and intracellular glutathione protects astrocytes from Zn2+-induced cell death. Neuroreport 14 (2003) 187-190
28. Requena J.R., Fu M.X., Ahmed M.U., Jenkins A.J., Lyons T.J., and Thorpe S.R. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 5 (1996) 48-53
29. Romero F.J., Bosch-Morell F., Romero M.J., Jareno E.J., Romero B., Marin N., and Roma J. Lipid peroxidation products and antioxidants in human disease. Environ. Health Perspect. 5 (1998) 1229-1234
30. Youdim M.B., Ben-Shachar D., Eshel G., Finberg J.P., and Riederer P. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease. Adv. Neurol. 60 (1993) 259-266
31. Liochev S.I. The mechanism of "Fenton-like" reactions and their importance for biological systems. A biologist's view. Met. Ions. Biol. Syst. 36 (1999) 1-39
32. Kehrer J.P. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149 (2000) 43-50
33. Kukreja R.C., Kontos H.A., Hess M.L., and Ellis E.F. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ. Res. 59 (1986) 612-619
34. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271 (1996) 33157-33160
35. Pasinetti G.M. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J. Neurosci. Res. 54 (1998) 1-6
36. Marnett L.J. Cyclooxygenase mechanisms. Curr. Opin. Chem. Biol. 4 (2000) 545-552
37. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
38. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
39. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. third ed. (1999), Oxford Univ. Press, New York
40. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17 (1997) 2746-2755
41. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., and Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. USA 95 (1998) 10954-10959
42. Nogawa S., Forster C., Zhang F., Nagayama M., Ross M.E., and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc. Natl. Acad. Sci. USA 95 (1998) 10966-10971
43. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., and Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155 (1999) 995-1004
44. Pepicelli O., Fedele E., Berardi M., Raiteri M., Levi G., Greco A., Ajmone-Cat M.A., and Minghetti L. Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus. J. Neurochem. 93 (2005) 1561-1567
45. Hall E.D., Andrus P.K., Althaus J.S., and VonVoigtlander P.F. Hydroxyl radical production and lipid peroxidation parallels selective post-ischemic vulnerability in gerbil brain. J. Neurosci. Res. 34 (1993) 107-112
46. Tyurin V.A., Tyurina Y.Y., Borisenko G.G., Sokolova T.V., Ritov V.B., Quinn P.J., Rose M., Kochanek P., Graham S.H., and Kagan V.E. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J. Neurochem. 75 (2000) 2178-2189
47. Miyamoto O., Tamae K., Kasai H., Hirakawa H., Hayashida Y., Konishi R., and Itano T. Suppression of hyperemia and DNA oxidation by indomethacin in cerebral ischemia. Eur. J. Pharmacol. 459 (2003) 179-186
48. Armstead W.M. Vasopressin induced cyclooxygenase dependent superoxidegeneration contributes to K(+) channel function impairment after brain injury. Brain Res. 910 (2001) 19-28
49. Kulkarni M., and Armstead W.M. Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury. J. Neurotrauma 19 (2002) 965-973
50. Dexter D.T., Wells F.R., Agid F., Agid Y., Lees A.J., Jenner P., and Marsden C.D. Increased nigral iron content in postmortem parkinsonian brain. Lancet 21 (1987) 1219-1220
51. Smith M.A., Harris P.L., Sayre L.M., and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94 (1997) 9866-9868
52. Bolann B.J., and Ulvik R.J. Stimlated decay of O2-* caused by ferritin-bound copper. FEBS Lett. 328 (1993) 263-267
53. Prasad M.R., Engelman R.M., Jones R.M., and Das D.K. Effects of oxyradicals on oxymyoglobin. Deoxygenation, haem removal and iron release. Biochem. J. 263 (1989) 731-736
54. Nagababu E., and Rifkind J.M. Formation of fluorescent heme degradation products during the oxidation of hemoglobin by hydrogen peroxide. Biochem. Biophys. Res. Commun. 247 (1998) 592-596
55. Prasad K.N., Hovland A.R., La Rosa F.G., and Hovland P.G. Prostaglandins as putative neurotoxins in Alzheimer's disease. Proc. Soc. Exp. Biol. Med. 219 (1998) 120-125
56. Rohn T.T., Wong S.M., Cotman C.W., and Cribbs D.H. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. Neuroreport 12 (2001) 839-843
57. Takadera T., Yumoto H., Tozuka Y., and Ohyashiki T. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci. Lett. 317 (2002) 61-64
58. Manabe Y., Anrather J., Kawano T., Niwa K., Zhou P., Ross M.E., and Iadecola C. Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity. Ann. Neurol. 55 (2004) 668-675
59. Victor V.M., Rocha M., and De la Fuente M. N-Acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic. Res. 37 (2003) 919-929
60. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5 (2004) 347-360
61. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12 (1998) 1063-1073